NHCP VIII received strong support from both existing and new investors, raising capital from leading institutional investors, high-net-worth family offices, and individual clients of Morgan Stanley ...

Discover how GLP-1 drugs are driving demand for new supplements. Insights from Vitafoods Europe 2025 reveal how the industry ...

Morgan Stanley Capital Partners ("MSCP") acquired Thermogenics as part of a new investment in the company that closed on June 10, 2025. Terms of the deal are not disclosed. "Thermogenics represented ...

To date, Fund VIII has deployed approximately 17% of committed capital across three investments: American Restoration, a residential and commercial property mitigation and restoration services company ...

As of 06/13/2025. Team and portfolio information may change from time to time. Includes legacy energy investments executed by the investment team prior to 2015. All energy, oil and gas, and natural ...